Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jens Claus Hahne
New Developments in the Treatment of Chemotherapy-Induced Neutropenia: Focus on Balugrastim
Therapeutics and Clinical Risk Management
Related publications
New Developments in the Treatment of Advanced Squamous Cell Lung Cancer: Focus on Afatinib
OncoTargets and Therapy
Oncology
Pharmacology
New Advancements and Developments in Treatment of Renal Cell Carcinoma: Focus on Pazopanib
OncoTargets and Therapy
Oncology
Pharmacology
Identification of Targets and New Developments in the Treatment of Multiple Sclerosis &Ndash; Focus on Cladribine
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Role of Myeloid Growth Factors in Chemotherapy Induced Neutropenia
International Journal of Basic and Clinical Pharmacology
Chemotherapy-Induced Neutropenia in Pediatric Leukemia: Persian Medicine Perspective
Galen Medical Journal
Medicine
New Developments in the Treatment of Basal Cell Carcinoma: Update on Current and Emerging Treatment Options With a Focus on Vismodegib
OncoTargets and Therapy
Oncology
Pharmacology
Update and Developments in the Treatment of Glioblastoma Multiforme &Ndash; Focus on Bevacizumab
Pharmacogenomics and Personalized Medicine
Molecular Medicine
Pharmacology
New Developments in the Management of Overactive Bladder: Focus on Mirabegron and onabotulinumtoxinA
Therapeutics and Clinical Risk Management
Medical Visits for Chemotherapy and Chemotherapy-Induced Neutropenia: A Survey of the Impact on Patient Time and Activities
BMC Cancer
Cancer Research
Oncology
Genetics